Current position:Home >Product >
(4R)-N-(4-chlorophenyl)-2-oxidanylidene-1-phenethyl-3,4-dihydropyrimido[1,2-a]benzimidazole-4-carboxamide
(4R)-N-(4-chlorophenyl)-2-oxidanylidene-1-phenethyl-3,4-dihydropyrimido[1,2-a]benzimidazole-4-carboxamide
|
|
Canonical SMILES:
C1C(N2C3=CC=CC=C3N=C2N(C1=O)CCC4=CC=CC=C4)C(=O)NC5=CC=C(C=C5)Cl
Isomeric SMILES
C1[C@@H](N2C3=CC=CC=C3N=C2N(C1=O)CCC4=CC=CC=C4)C(=O)NC5=CC=C(C=C5)Cl
InChI
InChI=1S/C25H21ClN4O2/c26-18-10-12-19(13-11-18)27-24(32)22-16-23(31)29(15-14-17-6-2-1-3-7-17)25-28-20-8-4-5-9-21(20)30(22)25/h1-13,22H,14-16H2,(H,27,32)/t22-/m1/s1
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 2-[(3-bromanyl-4-methoxy-phenyl)sulfonylamino]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
- 4-chloranyl-N-(3-morpholin-4-ium-4-ylpropyl)-3-(phenylsulfamoyl)benzamide
- 2-[(3-chloranyl-4-methoxy-phenyl)sulfonylamino]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
- 2-[(2S,3E)-2-(3-nitrophenyl)-3-[(4-nitrophenyl)-oxidanyl-methylidene]-4,5-bis(oxidanylidene)pyrrolidin-1-yl]ethanoate
- 2-[(2S,3E)-2-(3-nitrophenyl)-3-[(4-nitrophenyl)-oxidanyl-methylidene]-4,5-bis(oxidanylidene)pyrrolidin-1-yl]ethanoic acid
- 1-[2-(cyclohexen-1-yl)ethyl]-5-[[1-(phenylmethyl)piperidin-1-ium-4-yl]iminomethyl]-1,3-diazinane-2,4,6-trione
- 1-[2-(cyclohexen-1-yl)ethyl]-5-[[1-(phenylmethyl)piperidin-4-yl]iminomethyl]-1,3-diazinane-2,4,6-trione
- [(2S)-2-(4-ethylphenyl)-1-(6-fluoranyl-1,3-benzothiazol-2-yl)-4,5-bis(oxidanylidene)pyrrolidin-3-ylidene]-[(2S)-2-methyl-2,3-dihydro-1-benzofuran-5-yl]methanolate
- 2-[(4-methoxyphenyl)sulfonylamino]-N-[[(2R)-oxolan-2-yl]methyl]benzamide
- (5S)-5-(4-ethylphenyl)-1-(6-fluoranyl-1,3-benzothiazol-2-yl)-4-[[(2S)-2-methyl-2,3-dihydro-1-benzofuran-5-yl]-oxidanyl-methylidene]pyrrolidine-2,3-dione

